High-Impact Improvements & Content Roadmap

A comprehensive, regularly updated directory covering medical cannabis laws, qualifying conditions, possession limits, dispensary regulations, and patient registration requirements for all 50 US states plus DC. Each state gets its own indexed page with structured data. Massive long-tail SEO opportunity — "medical marijuana laws [state]" queries drive millions of monthly searches.

Side-by-side comparison of THC, CBD, CBG, CBN, THCV, CBC, and other cannabinoids across pharmacology, receptor affinity, therapeutic applications, side effects, and legal status. Interactive filtering by condition, route of administration, and evidence level. Highly shareable, link-worthy resource for clinicians and researchers.

Long-form, evidence-graded patient guides for the top conditions people research cannabis for: PTSD, fibromyalgia, Crohn's disease, multiple sclerosis, Parkinson's, ALS, glaucoma, migraines, ADHD, endometriosis, lupus, rheumatoid arthritis, and more. Each guide covers: what the research shows, evidence quality rating, typical protocols studied, risks, and questions to ask your doctor.

The current interactions page covers ~20 drugs. Expand to 100+ common medications with detailed mechanism explanations, severity ratings (minor/moderate/major), clinical management guidance, and citations. Add a search/filter UI. This is one of the highest-value professional resources possible — physicians actively search for this data.

Make newsletter back issues publicly accessible as indexed HTML pages (not just email). Each issue becomes a standalone page with its own URL, title, and meta description. Covers new study summaries, researcher spotlights, and clinical updates. Builds topical authority over time and gives subscribers a reason to share links.

A comprehensive, visually rich explainer covering ECS anatomy, CB1/CB2 receptor distribution, endogenous cannabinoids (anandamide, 2-AG), retrograde signaling, and how phytocannabinoids interact with the system. Include an interactive body map showing receptor distribution. The definitive ECS resource on the web — currently a gap in quality content.

Enhance the existing trials page with real-time status indicators, phase progression tracking, enrollment status, and estimated completion dates. Add email alerts for trial status changes. Group by condition, compound, and phase. Link each trial to relevant topic hubs and study pages for internal linking density.

An interactive tool that presents studied dosing ranges from clinical trials, organized by condition, route of administration (oral, sublingual, inhaled, topical), and cannabinoid ratio. Not a prescribing tool — clearly framed as "what doses have been studied" with evidence citations. Fills a major gap: patients and clinicians have no reliable reference for studied dose ranges.

Individual pages for every major cannabis terpene: myrcene, limonene, linalool, pinene, caryophyllene, humulene, terpinolene, ocimene, and 20+ more. Each profile covers: aroma, plant sources, pharmacological research, potential therapeutic effects, and which cannabis strains are highest in that terpene. Currently only a single terpenes overview page exists.

Q&A interviews with leading cannabinoid researchers covering their current work, key findings, and perspectives on the field. Published as both video embeds and full text transcripts (for SEO). Each interview links to the researcher's profile and relevant studies. Builds authority, earns backlinks, and creates shareable content.

Track federal and state cannabis legislation in real time: pending bills, recent changes, DEA scheduling updates, FDA guidance, and international policy developments. Each policy item links to relevant research on the underlying science. Positions the platform as the go-to source for policy-adjacent research context.

Dedicated section covering cannabinoid research in pediatric populations: epilepsy (Dravet, Lennox-Gastaut), autism spectrum disorder, pediatric cancer, and ADHD. Includes parent/caregiver guides, evidence summaries, and links to active trials. Highly sensitive topic requiring careful evidence grading — but enormous unmet information need.

Dedicated resource for veterans and PTSD research: clinical trials, VA policy, state medical program access for veterans, researcher profiles specializing in PTSD, and patient advocacy resources. One of the most politically and emotionally resonant cannabis research topics — high traffic, high sharing, strong advocacy community.

For each major systematic review and meta-analysis in the research library, add a 300-500 word plain-language summary written for non-specialists. Include a "What This Means" section, evidence quality rating, and limitations. Makes the research library accessible to patients and journalists, not just clinicians.

Balanced, evidence-based coverage of cannabis risks: psychosis risk factors, adolescent brain development, cardiovascular risks, cannabinoid hyperemesis syndrome, impaired driving, dependency, and drug interactions. Critically important for platform credibility — a research platform that only covers benefits loses trust.

Coverage of cannabis research programs, medical cannabis regulations, and clinical trial activity in key international markets: Israel (birthplace of cannabinoid research), Netherlands, Germany, Canada, Australia, UK, and Brazil. Each country page covers regulatory framework, key researchers, notable studies, and patient access.

Develop 5-10 accredited continuing medical education modules on cannabinoid medicine: ECS pharmacology, clinical applications, patient counseling, drug interactions, and special populations. Partner with an accreditation body (ACCME, ACPE). Drives professional portal subscriptions and positions the platform as a legitimate medical education resource.

Expand the evidence standards page with a detailed FAQ, worked examples showing how each evidence level is assigned, comparison to other grading systems (GRADE, Oxford), and a visual flowchart. Add a "How to Read a Cannabis Study" guide for patients. Builds trust and differentiates the platform from non-evidence-based cannabis sites.

A curated, editorially reviewed news feed of new cannabis research publications, FDA/DEA announcements, clinical trial results, and policy changes. Updated weekly. Each item links to the primary source and relevant platform pages. Freshness signals improve crawl frequency and give returning visitors a reason to check back.

Anonymized, IRB-style patient case summaries describing real-world cannabis use outcomes alongside the relevant research. Not testimonials — structured case reports with condition, treatment approach, outcomes, and links to supporting studies. Humanizes the research and improves engagement metrics.

Restructure content around formal topic clusters: each major topic hub (pain, anxiety, sleep, etc.) becomes a pillar page with 8-12 supporting spoke articles targeting specific long-tail queries. Example: Pain pillar → spokes for "cannabis for back pain research", "CBD for neuropathic pain", "THC vs CBD for pain", "cannabis opioid alternative studies". Internal linking between pillar and spokes.

Add schema.org/MedicalCondition markup to all topic hub pages, schema.org/Drug markup to all compound pages, and schema.org/MedicalStudy markup to all research library entries. This enables rich results in Google Search for medical queries and signals E-E-A-T to search engines.

Add FAQPage schema markup to every topic hub and compound page with 4-6 common questions and evidence-based answers. FAQ rich results appear directly in Google SERPs, dramatically increasing click-through rates. Currently only Q&A detail pages have this markup.

Geo-targeted landing pages for major US metro areas covering: local dispensaries with medical programs, nearby clinical trial sites, state-specific laws, and local healthcare providers who discuss cannabis. Targets "medical marijuana [city]" and "cannabis research [state]" queries — extremely high commercial intent.

Expand each minor cannabinoid page (CBG, CBN) and add new pages for THCV, CBC, CBDV, and CBDA. Each page should cover: molecular structure, biosynthesis, receptor pharmacology, current research status, potential therapeutic applications, and comparison to CBD/THC. Minor cannabinoids are a fast-growing search category.

A structured 6-module certificate program for healthcare professionals covering: ECS pharmacology, clinical evidence review, patient assessment, dosing principles, drug interactions, and legal/ethical considerations. Issued as a verifiable digital certificate. Monetization opportunity and major credibility signal.

A practical guide for patients, journalists, and non-specialists on how to critically evaluate cannabis studies: understanding RCTs vs. observational studies, placebo effects, sample sizes, funding bias, and how to read abstracts. Positions the platform as a media literacy resource and earns links from journalism schools and fact-checkers.